These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2145968)

  • 1. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies.
    Malia RG; Kitchen S; Greaves M; Preston FE
    Br J Haematol; 1990 Sep; 76(1):101-7. PubMed ID: 2145968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.
    McNeil HP; Chesterman CN; Krilis SA
    Br J Haematol; 1989 Dec; 73(4):506-13. PubMed ID: 2514785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?
    Oosting JD; Derksen RH; Bobbink IW; Hackeng TM; Bouma BN; de Groot PG
    Blood; 1993 May; 81(10):2618-25. PubMed ID: 8166780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cells.
    Borrell M; Sala N; de Castellarnau C; Lopez S; Gari M; Fontcuberta J
    Thromb Haemost; 1992 Sep; 68(3):268-72. PubMed ID: 1440490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the relationship between 'antiphospholipid' antibodies and the lupus anticoagulant.
    Exner T; McRea J
    Blood Coagul Fibrinolysis; 1990; 1(1):17-21. PubMed ID: 2129389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
    McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
    Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis.
    Amer L; Kisiel W; Searles RP; Williams RC
    Thromb Res; 1990 Jan; 57(2):247-58. PubMed ID: 2107591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; ViganĂ² D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
    Tsakiris DA; Settas L; Makris PE; Marbet GA
    J Rheumatol; 1990 Jun; 17(6):785-9. PubMed ID: 2167370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticardiolipin antibodies in patients with venous thrombosis.
    Kapiotis S; Speiser W; Pabinger-Fasching I; Kyrle PA; Lechner K
    Haemostasis; 1991; 21(1):19-24. PubMed ID: 1907589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels.
    Walker TS; Triplett DA; Javed N; Musgrave K
    Thromb Res; 1988 Aug; 51(3):267-81. PubMed ID: 2972088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding specificity of lupus anticoagulants and anticardiolipin antibodies.
    McNeil HP; Chesterman CN; Krilis SA
    Thromb Res; 1988 Dec; 52(6):609-19. PubMed ID: 3148207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-beta(2)-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein I to phospholipids.
    Izumi T; Pound ML; Su Z; Iverson GM; Ortel TL
    Thromb Haemost; 2002 Oct; 88(4):620-6. PubMed ID: 12362233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity.
    Permpikul P; Rao LV; Rapaport SI
    Blood; 1994 May; 83(10):2878-92. PubMed ID: 8180383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of lupus anticoagulant with antibody against phosphatidylserine.
    Branch DW; Rote NS; Dostal DA; Scott JR
    Clin Immunol Immunopathol; 1987 Jan; 42(1):63-75. PubMed ID: 3098482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
    Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets.
    Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
    Thromb Haemost; 1990 Apr; 63(2):169-73. PubMed ID: 2114042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant.
    Marciniak E; Romond EH
    Blood; 1989 Nov; 74(7):2426-32. PubMed ID: 2508795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.